Availability of the 3rd platelet factor in healthy children
Lacki, L.; Chlubek, S.
Acta Haematologica Polonica 6(2): 137-142
1975
ISSN/ISBN: 0001-5814 PMID: 1154988 Document Number: 93203
In 34 healthy children at school-age the availability of the 3rd platelet factor was determined using plasma of mean concentrations of 100 000 and 342 000 platelets/mm3. The concentration of 100 000 platelets/mm3 gives very approximate results to those obtained with the higher concentration. Both curves of availability of this factor showed many features in common. The highest activity of the factor was observed from 0 to 10--15 min. of the incubation and after this peak it decreased gradually. The authors present and discuss the types of curves indicating physiological values.
Document emailed within 1 workday
Related Documents
Dillingham, E.O.; Lasslo, A.; Gollamudi, R.; Bond, S.E.; Carter-Burks, G. 1990: The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability Research Communications in Chemical Pathology and Pharmacology 67(2): 179-199Reuter, H.D.; Schröter, G. 1980: Potassium, magnesium, copper, manganese and cobalt salts of aspartic acid on platelet factor 3 availability Arzneimittel-Forschung 30(12): 2106-2108
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Zuch, A.; Rudobielska, M.; Zwierzowa, W.; Jurgielewicz, E.; Buluk, K. 1972: Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children Pediatria Polska 47(10): 1197-1203
Hirschman, R.J.; Gralnick, H.R. 1974: A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE Journal of Laboratory and Clinical Medicine 84(2): 292-297
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Choo, J.; Yang, H-Mi.; Jae, S-Young.; Kim, H-Jin.; You, J.; Lee, J. 2020: Effects of the Healthy Children, Healthy Families, Healthy Communities Program for Obesity Prevention among Vulnerable Children: A Cluster-Randomized Controlled Trial International Journal of Environmental Research and Public Health 17(8)
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Erikssen, J.; Hellem, A.; Stormorken, H. 1977: Chronic effect of smoking on platelet count and "platelet adhesiveness" in presumably healthy middle-aged men Thrombosis and Haemostasis 38(3): 606-611
Jaruratanasirikul, S.; Leethanaporn, K.; Pradutkanchana, S.; Sriplung, H. 1999: Serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in healthy Thai children and adolescents: relation to age, sex, and stage of puberty Journal of the Medical Association of Thailand 82(3): 275-283
Jaruratanasirikul, S.; Sriplung, H.; Leethanaporn, K. 1999: Serum insulin-like growth factor-1 (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) in healthy Thai children and adolescents: relation to height, weight, and body mass index Journal of the Medical Association of Thailand 82(10): 984-990
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Ikonnikov, V.I. 1972: Age and climatic-geographic aspects of complement and rheumatoid factor titer in healthy children Laboratornoe Delo 7: 440-442
Holt, J.C.; Niewiarowski, S. 1989: Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification Methods in Enzymology 169: 224-233
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
Duquesnoy, R.J.; Vieira, J.; Aster, R.H. 1977: Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients Transplantation Proceedings 9(1): 519-521
Pfueller, S.L.; Howard, M.A.; White, J.G.; Menon, C.; Berry, E.W. 1987: Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome Thrombosis and Haemostasis 58(4): 1060-1063
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320